Literature DB >> 8950070

Cytotoxicity of amiodarone in cultured human endothelial cells.

B Baudin1, B Bénéteau-Burnat, J Giboudeau.   

Abstract

As damage to the pulmonary vascular endothelium may be responsible for the lung toxicity of amiodarone, we evaluated the cytolytic toxicity of the drug in cultures of endothelial cells. Cells were cultured from human umbilical cord veins. Amiodarone caused a vacuolization of the cells with liberation of both lactate dehydrogenase (LDH) and angiotensin-converting enzyme (ACE) in the culture medium. These effect were both concentration and time dependent, and were correlated between them. The first toxic effects were shown as soon as 2 hours after contact with the drug and at 0.1 mg/ml, a concentration that can be reached in plasma of amiodarone-treated patients. A decrease of ACE activity in the cells was delayed to 24 hours and only with the 10 mg/ml concentration. This event correlated with cell death and detachment from the extracellular matrix. LDH increases corresponded to its isoenzymes 3 and 4. These data support the hypothesis of a direct toxic effect of amiodarone on the endothelium and show the need for evaluating LDH, total activity and isoenzymic profile, and ACE determinations in the plasma of patients treated with amiodarone for ischemic heart disease or arrhythmia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950070     DOI: 10.1007/bf00050996

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  13 in total

1.  Lung injury by amiodarone, an antiarrhythmic drug, in male rats.

Authors:  B Padmavathy; S Niranjali; H Devaraj
Journal:  Indian J Exp Biol       Date:  1992-07       Impact factor: 0.818

2.  Angiotensin-converting enzyme as a possible marker for lung toxicity in amiodarone-treated patients.

Authors:  V Foresti; R Pepe; E Parisio; G De Filippi; N Scolari; C Frigerio
Journal:  Int J Clin Pharmacol Res       Date:  1989

Review 3.  Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy.

Authors:  A T Canada; L J Lesko; C I Haffajee; B Johnson; G K Asdourian
Journal:  Drug Intell Clin Pharm       Date:  1983-02

Review 4.  Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.

Authors:  F I Marcus; G H Fontaine; R Frank; Y Grosgogeat
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

5.  Enzymatic responses to radiation in cultured vascular endothelial and smooth muscle cells.

Authors:  D B Rubin; E A Drab; W F Ward; L J Smith; S M Fowell
Journal:  Radiat Res       Date:  1984-08       Impact factor: 2.841

6.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Amiodarone pulmonary toxicity.

Authors:  F E Marchlinski; T S Gansler; H L Waxman; M E Josephson
Journal:  Ann Intern Med       Date:  1982-12       Impact factor: 25.391

8.  Pharmacokinetics of amiodarone in rats.

Authors:  E Riva; M Gerna; P Neyroz; R Urso; I Bartosek; A Guaitani
Journal:  J Cardiovasc Pharmacol       Date:  1982 Mar-Apr       Impact factor: 3.105

9.  Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.

Authors:  W J Martin; D M Howard
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

10.  In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.

Authors:  B Baudin; L Drouet
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.